Maxcyte (MXCT) EBITDA Margin (QoQ) (2020 - 2026)
Maxcyte (MXCT) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37,281.00 |
| Dec 31, 2025 | 44,259.00 |
| Sep 30, 2025 | -3,995.00 |
| Jun 30, 2025 | -4,890.00 |
| Mar 31, 2025 | 9,473.00 |
| Dec 31, 2024 | -4,093.00 |
| Sep 30, 2024 | 6,896.00 |
| Jun 30, 2024 | -2,127.00 |
| Mar 31, 2024 | -18,933.00 |
| Dec 31, 2023 | 30,521.00 |
| Sep 30, 2023 | -19,114.00 |
| Jun 30, 2023 | 12,091.00 |
| Mar 31, 2023 | -17,844.00 |
| Dec 31, 2022 | -1,457.00 |
| Sep 30, 2022 | 1,849.00 |
| Jun 30, 2022 | -5,506.00 |
| Mar 31, 2022 | 3,013.00 |
| Dec 31, 2021 | -4,193.00 |
| Sep 30, 2021 | 3,805.00 |
| Jun 30, 2021 | 8,820.00 |